INTERPOL and the United States’s Homeland Security Investigations (HSI) have joined forces to warn the public against purchasing alleged COVID-19 vaccines and treatments online.
According to a statement released by the organization on its official website, it stated that:
“With criminal groups producing, distributing and selling fake vaccines, the risks to the public are clear: these can include buying a product which not only does not protect against COVID-19, but poses a serious health hazard if ingested or injected. Such products are not tested, regulated or safety-checked.
“Legitimate vaccines are not for sale. They are strictly administered and distributed by national healthcare regulators.
“Anyone buying these products online also runs the risk of potentially giving their money to organized criminals.” It stated
“From the very beginning of the pandemic, criminals have preyed on people’s fears in order to make fast cash. Fake vaccines are the latest in these scams, which is why INTERPOL and HSI are warning the public to be extra vigilant,” said INTERPOL Secretary General Jürgen Stock.
“Anyone ordering a vaccine online rather than obtaining it from their national provider, will be buying a fake product.”
“The networks behind these crimes have global ambitions. No country or region can fight this type of crime alone. INTERPOL is assisting law enforcement around the world to both identify criminal networks and to dismantle them,” added Secretary General Stock.
Following a global alert issued by INTERPOL in late 2020 the world police body recently announced the first internationally linked arrests and seizures in connection with fake vaccines after criminal networks were disrupted in China and South Africa.
INTERPOL has also been receiving additional information on fake vaccine distribution and scam attempts targeting health bodies, including nursing homes.
“Counterfeit vaccines threaten the health of consumers who are duped by nefarious actors seeking to exploit the pandemic situation for financial gain.
“HSI and its law enforcement partners will vigorously investigate and seek prosecution for criminals taking advantage of the public’s quest for COVID-19 vaccinations and those who endanger the lives of the very people the vaccines are intended to protect,” said HSI Assistant Director, and Director of the National Intellectual Property Rights Coordination Center, Steve Francis.
“HSI will continue to work with INTERPOL to coordinate investigations targeting every level of the transnational criminal organizations trafficking in counterfeit COVID-19 vaccines,” added Mr Francis.
An emerging trend has seen cybercriminals set up illicit websites claiming to be legitimate national and/or world organizations offering pre-orders for vaccines against the COVID-19 virus. These websites offer payments in Bitcoins and other payment processing methods.
Using trademark logos of major pharmaceutical companies producing approved COVID-19 vaccines, the fake websites are suspected of being used to conduct phishing attacks and/or dupe victims into giving charitable donations.
In addition to opening up their computer to cyberattacks when attempting to purchase alleged COVID-19 vaccines online, people also run the risk of having their identity stolen.
In December 2020, HSI seized two websites purporting to be those of biotechnology companies developing treatments for the COVID-19 virus. Instead they appeared to have been used to collect the personal information of individuals visiting the sites, in order to use the information for criminal purposes, including fraud, phishing attacks, and/or deployment of malware.
Ransomware attacks have also been conducted against hospitals, laboratories, local governments and other targets, remotely blocking computer systems and demanding a payment to release them.
Given the need for a global response against these types of cyber-enabled fraud and financial crime, INTERPOL created the Global Financial Crime Task Force (IGFCTF) in 2020 with member countries in order to enhance international cooperation and innovation with public and private sector partners.